153 related articles for article (PubMed ID: 11591125)
1. Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis.
Jensen P; Johansen HK; Carmi P; Høiby N; Cohen IR
J Autoimmun; 2001 Sep; 17(2):165-72. PubMed ID: 11591125
[TBL] [Abstract][Full Text] [Related]
2. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
Jensen P; Johansen HK; Lanng S; Høiby N
Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
[TBL] [Abstract][Full Text] [Related]
3. Glucose intolerance in cystic fibrosis patients.
Lanng S
Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
[TBL] [Abstract][Full Text] [Related]
4. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
5. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides.
Abulafia-Lapid R; Elias D; Raz I; Keren-Zur Y; Atlan H; Cohen IR
J Autoimmun; 1999 Mar; 12(2):121-9. PubMed ID: 10047432
[TBL] [Abstract][Full Text] [Related]
6. The clonal antibody response to Pseudomonas aeruginosa heat shock protein is highly diverse in cystic fibrosis patients.
Ulanova M; Petersen TD; Ciofu O; Jensen P; Hahn-Zoric M; Hanson LA; Høiby N
APMIS; 1997 Jun; 105(6):449-56. PubMed ID: 9236862
[TBL] [Abstract][Full Text] [Related]
7. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
Preumont V; Hermans MP; Lebecque P; Buysschaert M
Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
[TBL] [Abstract][Full Text] [Related]
8. Clinical importance of cystic fibrosis-related diabetes.
Brennan AL; Geddes DM; Gyi KM; Baker EH
J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
[TBL] [Abstract][Full Text] [Related]
9. [Glucose intolerance and diabetes during cystic fibrosis].
Tubiana-Rufi N; Czernichow P
Ann Pediatr (Paris); 1991 Apr; 38(4):244-8. PubMed ID: 2069359
[TBL] [Abstract][Full Text] [Related]
10. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
[TBL] [Abstract][Full Text] [Related]
11. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.
Dieudé M; Senécal JL; Raymond Y
Arthritis Rheum; 2004 Oct; 50(10):3221-31. PubMed ID: 15476243
[TBL] [Abstract][Full Text] [Related]
12. Calpain 10 and development of diabetes mellitus in cystic fibrosis.
Derbel S; Doumaguet C; Hubert D; Mosnier-Pudar H; Grabar S; Chelly J; Bienvenu T
J Cyst Fibros; 2006 Jan; 5(1):47-51. PubMed ID: 16377260
[TBL] [Abstract][Full Text] [Related]
13. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
[TBL] [Abstract][Full Text] [Related]
14. Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells?
Ali BR
Med Hypotheses; 2009 Jan; 72(1):55-7. PubMed ID: 18851900
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
[TBL] [Abstract][Full Text] [Related]
16. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.
Costa M; Potvin S; Hammana I; Malet A; Berthiaume Y; Jeanneret A; Lavoie A; Lévesque R; Perrier J; Poisson D; Karelis AD; Chiasson JL; Rabasa-Lhoret R
J Cyst Fibros; 2007 Nov; 6(6):376-83. PubMed ID: 17409029
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
18. Demographics of glucose metabolism in cystic fibrosis.
van den Berg JM; Kouwenberg JM; Heijerman HG
J Cyst Fibros; 2009 Jul; 8(4):276-9. PubMed ID: 19467621
[TBL] [Abstract][Full Text] [Related]
19. ZnT8 antibodies in patients with cystic fibrosis: an expression of secondary beta-cell damage?
Bizzarri C; Giannone G; Benevento D; Montemitro E; Alghisi F; Cappa M; Lucidi V
J Cyst Fibros; 2013 Dec; 12(6):803-5. PubMed ID: 23535193
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
